Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Female pattern hair loss shows similar characteristics in both genders and should be classified by hair loss patterns, not gender.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Low iron levels may be linked to hair loss in women.

Nonactivated low leukocyte PRP injections can significantly increase hair and follicle density in women with alopecia.

Higher bad cholesterol levels are linked to more severe female pattern hair loss.

Hair restoration surgery can effectively treat hair loss in women.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

Women with telogen effluvium have lower levels of VEGF, which may contribute to their hair loss.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

Hairpieces improve quality of life for women with hair loss.

Women with chronic hair loss had lower levels of zinc, copper, and ferritin than healthy women.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Alitretinoin may cause irreversible hair curling as a side effect.

Ciproterone acetate improves hair regrowth and acne in most female patients.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Low serum ferritin levels are not closely linked to telogen effluvium in women.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Serum ferritin levels do not cause hair loss in women with telogen effluvium.

Trichoscopic features can help dermatologists distinguish between female pattern hair loss and chronic telogen effluvium.

Finasteride improves acne and hair loss in women with normal testosterone.